Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors
Phase I
Phase I
This is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 in subjects with advanced or metastatic solid tumors.
Phase I
I
Das, Satya
NCT04900818
VICCPHI2151